HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
EDIT holding history
Editas Medicine, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EDIT overviewAll 13F holders of EDITFull Q2 2026 holdings
- Shares (Q2 2026)
- 210
- Value
- $681
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 210 | $681 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 210 | $519 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 210 | $431 | <0.1% | −25−10.6% | Reduced | Holders |
| Q3 2025 | 235 | $816 | <0.1% | +25+11.9% | Added | Holders |
| Q2 2025 | 210 | $462 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 210 | $244 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 210 | $267 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 210 | $717 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 210 | $981 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 210 | $1.56K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 210 | $2.13K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 210 | $1.64K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 210 | $1.73K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 210 | $1.52K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 210 | $1.86K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 210 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 210 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 210 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 210 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 210 | $9.00K | <0.1% | +210 | New | Holders |